share_log

HC Wainwright & Co. Reiterates Buy on Acer Therapeutics, Maintains $12 Price Target

Benzinga ·  Mar 28, 2023 10:48

HC Wainwright & Co. analyst Vernon Bernardino reiterates Acer Therapeutics (NASDAQ:ACER) with a Buy and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment